France· FR:64224662
ROCLANDA 50 microgrammes/mL + 200 microgrammes/mL, collyre en solution
A medicinal product containing latanoprost + mésylate de nétarsudil, registered in France by SANTEN OY, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LATANOPROST + MÉSYLATE DE NÉTARSUDIL
- Manufacturer
- SANTEN OY
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302639211 flacon(s) polyéthylène basse densité (PEBD) de 2,5 ml avec embout(s) polyéthylène basse densité (PEBD) avec fermeture à témoin d'effractionEUR 7.26
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Latanoprost + mésylate de nétarsudil in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaROCLANDASanten OY, Tampere
- SpainROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCIONSanten Oy
- United KingdomRoclanda 50micrograms/ml + 200micrograms/ml eye dropsSanten UK Ltd
- SwitzerlandRoclanda, collyre en solutionSanten SA
- FinlandRoclandaParanova Oy
- NorwayRoclandaSanten Oy
- United StatesRocklatanAlcon Laboratories, Inc.
- SwedenRoclanda 50 mikrogram/ml + 200 mikrogram/ml Ögondroppar, lösningSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Roclanda
- Liechtenstein · Roclanda
- Norway · Roclanda
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/630775e8-5d68-4560-9be3-d97e3452f0dc GET /v1/drugs/630775e8-5d68-4560-9be3-d97e3452f0dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64224662",
"date_amm": "2021-01-07",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1502",
"substance": "LATANOPROST + MÉSYLATE DE NÉTARSUDIL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about latanoprost + mésylate de nétarsudil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.